Backs FY24 revenue view $3.865B-$3.890B, consensus $3.88B.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IDXX:
- Idexx Laboratories CFO Brian McKeon to retire, Andrew Emerson to succeed
- Idexx Laboratories Announces CEO Jonathan Ayers’ Resignation
- Idexx Laboratories price target lowered to $435 from $520 at Piper Sandler
- Idexx Laboratories price target lowered to $481 from $570 at Barclays
- IDEXX Laboratories Reports Robust Q3 2024 Performance